查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球液態栓塞劑市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按適應症、按最終用戶、按地區
市場調查報告書
商品編碼
1420309

全球液態栓塞劑市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按適應症、按最終用戶、按地區

Liquid Embolic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 280 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球液態栓塞劑市場規模為2.7億美元，預計2031年將達到約5.805億美元，複合年增長率（CAGR）為8.9%，預計將帶來顯著成長彈道。

目前液體栓塞瓶在全球市場佔據82.7%的主要份額。儘管液體栓塞產品已成功用於治療動靜脈畸形，但其在動脈瘤治療中的應用僅限於有限數量的患者，主要是由於擔心阻止液體遷移到載瘤血管中。

過去五年，全球液體栓塞劑市場以 4.2% 的複合年增長率擴張。栓塞是一種微創手術，用於阻塞一條或多條血管或異常血管通道。各種栓塞劑透過導管引入血管以阻止血液流向特定區域。液體栓塞劑如氰基丙烯酸正丁酯（NBCA）和乙基乙烯醇共聚物在栓塞治療中發揮重要作用。

預計未來十年對液體栓塞劑的需求將大幅成長，複合年增長率約為 8.9%。預計從 2024 年到 2031 年，這一成長將帶來 3.334 億美元的額外機會。與液體預填充注射劑相比，液體栓塞瓶預計在整個預測期內將保持較高的需求。

由於全球腫瘤發生率不斷增加，腫瘤栓塞為液體栓塞劑製造商帶來了重大機會。這種微創手術要麼切斷腫瘤的血液供應，要麼直接向腫瘤施用抗腫瘤藥物。

該報告研究了全球液體栓塞劑市場，並提供了市場概述，包括按產品、適應症、最終用戶、區域劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第三章 2018-2023年生產與貿易統計

第四章 2018-2023年價格分析

第五章 2018-2031 年全球液態栓塞劑市場展望

  • 全球液體栓塞劑市場展望，按產品，價值（百萬美元），數量（單位），2018-2031
  • 2018-2031 年全球液體栓塞劑市場前景（按適應症、價值（百萬美元）、數量（單位））
  • 全球液體栓塞劑市場展望，按最終用戶、價值（百萬美元）、數量（單位），2018-2031
  • 全球液體栓塞劑市場展望，按地區、價值（百萬美元）、數量（單位），2018-2031

第六章 北美液體栓塞劑市場展望，2018-2031

第 7 章 2018-2031 年歐洲液態栓塞劑市場展望

第 8 章 2018-2031 年亞太地區液體栓塞劑市場展望

第 9 章 2018-2031 年拉丁美洲液態栓塞劑市場展望

第 10 章 2018-2031 年中東和非洲液態栓塞劑市場展望

第十一章競爭格局

  • 最終用戶熱圖和指示
  • 2023 年公司市場份額分析
  • 比賽儀表板
  • 公司簡介
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Johnson & Johnson
    • Wright Medical Group N.V.
    • Microvention Inc.
    • Terumo Corporation
    • Guerbet
    • Emboflu
    • Boston Medical Corporation

第十二章附錄

簡介目錄

The global liquid embolic market, valued at US$ 270 million in 2024, is set to experience a significant growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 8.9% to reach a market valuation of approximately US$ 580.5 million by 2031, according to a recent market analysis by Fairfield Market.

Liquid Embolic Vials Dominate Market Share

Liquid embolic vials currently hold a substantial share of 82.7% in the global market. While liquid embolic products have been successfully used in the treatment of arteriovenous malformations, their application in aneurysm treatment remains limited to a select group of patients, primarily due to concerns about preventing the migration of the liquid to the parent vessel.

Demand Analysis and Growth Prospects

The global market for liquid embolics has expanded at a CAGR of 4.2% over the past five years. Embolization is a minimally invasive procedure used to block one or more blood vessels or abnormal vascular channels. Various embolic agents are introduced through catheters into blood vessels to inhibit blood flow to specific areas, with liquid embolic agents such as n-Butyl Cyanoacrylate (NBCA) and ethyl vinyl alcohol copolymers playing a vital role in therapeutic embolization.

The demand for liquid embolic products is expected to surge at a substantial rate over the next decade, with a projected CAGR of around 8.9%. This growth is anticipated to bring about an incremental opportunity of US$ 333.4 million from 2024 to 2031. Liquid embolic vials are expected to remain in high demand throughout the forecast period compared to liquid prefilled injectables.

Key Opportunities for Liquid Embolic Product Manufacturers

Tumor embolization presents a significant opportunity for liquid embolic product manufacturers, given the increasing incidence of tumors worldwide. This minimally invasive procedure involves shutting down the blood supply to tumors or delivering tumor-killing therapy directly to them.

Companies developing liquid embolic agents could expand their market share by pursuing regulatory approvals for indications beyond neuro interventional, tapping into the rising prevalence of cancer. Additionally, the growing demand for neurovascular embolization devices, driven by an increasing prevalence of cerebral aneurysms, offers further market growth prospects.

Advancements in research and development also provide opportunities for both emerging and established liquid embolic product suppliers to establish a strong presence in the market.

Factors Restraining Demand for Liquid Embolic Systems

While the demand for liquid embolic products is on the rise, certain challenges must be addressed. These include issues such as balloon deflation, catheter entrapment, and difficulties in deploying the device to the targeted lesion. Moreover, the high risk associated with liquid embolic procedures, including the potential of targeting the wrong blood vessels during surgical procedures, is a concern.

Additionally, limited liquid embolic agent manufacturers face intense competition from alternative transcatheter embolization devices, which could potentially restrain the growth of the liquid embolic systems market.

Country-wise Insights

The U.S.: Largest Regional Liquid Embolic Market

The United States dominates the North America liquid embolic market, with a substantial market share. This dominance is driven by factors such as unhealthy lifestyle habits, including junk food consumption, smoking, and alcohol use, as well as a sedentary lifestyle. These habits have led to a higher prevalence of chronic diseases like high blood pressure, migraines, and bAVM, increasing the demand for liquid embolic products and agents in the U.S. Moreover, lifestyle changes have been associated with a significant percentage of cancer cases in the country, further contributing to the demand for such products.

Germany: A Lucrative Market in Europe

Germany is expected to be a prominent player in the European market for liquid embolics. This is primarily due to the substantial number of clinical trials and research conducted in the country, particularly in the field of cancer research. Germany boasts a significant number of research ethics committees, with active government involvement in healthcare and cancer-related research and innovation. This environment presents lucrative opportunities for suppliers of liquid embolic products to grow in the market.

South Korea: An Emerging Market

South Korea is an emerging market in the East Asia liquid embolic market. The country is witnessing substantial growth in this sector, mainly due to the increasing prevalence of cardiovascular diseases. For instance, coronary heart disease-related deaths in South Korea have been a significant concern. This growth in cardiovascular issues has led to a rising demand for liquid embolic products and is expected to continue to expand in the coming years.

Competitive Analysis

Leading liquid embolic product providers are adopting growth strategies such as new product launches, approvals, agreements, collaborations, and partnerships. These strategies are helping key stakeholders expand their geographic footprint and strengthen their existing product portfolios.

Key Companies Profiled:

  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Johnson & Johnson
  • Microvention Inc.
  • Terumo Corporation
  • Guerbet
  • Emboflu

Key Segments Covered in Liquid Embolic Industry Research

Liquid Embolic Market by Product

  • Liquid Embolic Vials
  • Liquid Embolic Prefilled Injectables

Liquid Embolic Market by Indication

  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Radiology
  • Cardiology

Liquid Embolic Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Speciality Centres

Liquid Embolic Market by Region

  • North America Liquid Embolic Market
  • Latin America Liquid Embolic Market
  • Europe Liquid Embolic Market
  • East Asia Liquid Embolic Market
  • South Asia Liquid Embolic Market
  • Oceania Liquid Embolic Market
  • Middle East & Africa (MEA) Liquid Embolic Market

Table of Contents

1. Executive Summary

  • 1.1. Global Liquid Embolic Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Liquid Embolic Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Liquid Embolic Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Liquid Embolic Market Outlook, 2018 - 2031

  • 5.1. Global Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Liquid Embolic Vials
      • 5.1.1.2. Liquid Embolic Prefilled Injectables
  • 5.2. Global Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 5.2.1.2. Tumor Embolization
      • 5.2.1.3. Radiology
      • 5.2.1.4. Cardiology
  • 5.3. Global Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Ambulatory Surgical Centers
      • 5.3.1.3. Independent Speciality Centres
  • 5.4. Global Liquid Embolic Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Liquid Embolic Market Outlook, 2018 - 2031

  • 6.1. North America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Liquid Embolic Vials
      • 6.1.1.2. Liquid Embolic Prefilled Injectables
  • 6.2. North America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 6.2.1.2. Tumor Embolization
      • 6.2.1.3. Radiology
      • 6.2.1.4. Cardiology
  • 6.3. North America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Ambulatory Surgical Centers
      • 6.3.1.3. Independent Speciality Centres
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook, 2018 - 2031

  • 7.1. Europe Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Liquid Embolic Vials
      • 7.1.1.2. Liquid Embolic Prefilled Injectables
  • 7.2. Europe Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 7.2.1.2. Tumor Embolization
      • 7.2.1.3. Radiology
      • 7.2.1.4. Cardiology
  • 7.3. Europe Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Ambulatory Surgical Centers
      • 7.3.1.3. Independent Speciality Centres
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Liquid Embolic Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Liquid Embolic Vials
      • 8.1.1.2. Liquid Embolic Prefilled Injectables
  • 8.2. Asia Pacific Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 8.2.1.2. Tumor Embolization
      • 8.2.1.3. Radiology
      • 8.2.1.4. Cardiology
  • 8.3. Asia Pacific Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Ambulatory Surgical Centers
      • 8.3.1.3. Independent Speciality Centres
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Liquid Embolic Market Outlook, 2018 - 2031

  • 9.1. Latin America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Liquid Embolic Vials
      • 9.1.1.2. Liquid Embolic Prefilled Injectables
  • 9.2. Latin America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 9.2.1.2. Tumor Embolization
      • 9.2.1.3. Radiology
      • 9.2.1.4. Cardiology
  • 9.3. Latin America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Ambulatory Surgical Centers
      • 9.3.1.3. Independent Speciality Centres
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Liquid Embolic Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Liquid Embolic Vials
      • 10.1.1.2. Liquid Embolic Prefilled Injectables
  • 10.2. Middle East & Africa Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 10.2.1.2. Tumor Embolization
      • 10.2.1.3. Radiology
      • 10.2.1.4. Cardiology
  • 10.3. Middle East & Africa Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
      • 10.3.1.3. Independent Speciality Centres
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Indication Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Medtronic
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Meril Life Sciences Pvt. Ltd.
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Johnson & Johnson
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Wright Medical Group N.V.
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Microvention Inc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Terumo Corporation
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Guerbet
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Emboflu
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Boston Medical Corporation
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations